Is CPP therapy beneficial for all patients with high ICP?

Acta Neurochirurgica, Supplement

Volumn , Issue 81, 2002, Pages 67-68

  Oertel, M ^a   Kelly, Daniel F ^a   Lee, J H ^a   Glenn, T C ^a   Vespa, P M ^a   Martin, N A ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

CPP Therapy; ICP treatment; Intracranial hypertension

Indexed keywords

3-(2-CARBOXYPIPERAZIN-4-YL)PROPYL-1-PHOSPHONIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; ANTICONVULSIVE AGENT; PIPERAZINE DERIVATIVE;

ARTICLE; BLOOD PRESSURE; BRAIN INJURY; HUMAN; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; PATIENT MONITORING; PHYSIOLOGY;

ANTICONVULSANTS; BLOOD PRESSURE; BRAIN INJURIES; HUMANS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MONITORING, INTRAOPERATIVE; PIPERAZINES;

EID: 0035989088     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6738-0_16     Document Type: Conference Paper

References (7)

1. Characterization of cerebral hemodynamic phases following severe head trauma: Hypoperfusion, hyperemia, and vasospasm
2. Intracranial hypertension and cerebral perfusion pressure: Influence on neurological deterioration and outcome in severe head injury
3. Prevention of secondary ischemic insults after severe head injury
4. Cerebral perfusion pressure: Management protocol and clinical results
5. High cerebral perfusion pressure improves low values of local brain tissue O2 tension (PtiO2) in focal lesions
6. Multimodal monitoring in patients with head injury: Evaluation of the effects of treatment on cerebral oxygenation
7. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring